Clinical Trial Update: Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing ticagrelor to dipyridamole assessing adenosine uptake in patients with coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Dipyridamole (Dipyridamole)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Vanderbilt University | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED